Infringement Analysis · Spain

Infringement Analysis in Barcelona.

A patent infringement analysis Barcelona litigators rely on: PerspireIP maps claim charts and evidence-of-use for the Barcelona Commercial Courts. Get a quote.

patent infringement analysis Barcelona claim charts and evidence-of-use for pharma chemicals automotive and food-tech patent disputes by PerspireIP

A patent infringement analysis Barcelona litigators can build on has to be scoped for where these disputes actually land — the specialised commercial courts that have made Barcelona Spain’s leading patent forum, and a national enforcement track that sits deliberately outside the Unified Patent Court. Barcelona is the capital of Catalonia and the engine room of Spanish industry, home to the country’s densest pharmaceutical cluster, a heavy chemicals base, the SEAT and Volkswagen automotive complex at Martorell, and the 22@ innovation district’s food-tech and deep-tech start-ups. The patents asserted here read on formulations, chemical processes, vehicle systems and connected devices, and each case turns on evidence that the accused product actually practises the claim. PerspireIP builds the claim charts and evidence-of-use that prove — or defeat — that link.

Where a patent infringement analysis Barcelona case is decided

Barcelona is not an incidental venue for Spanish patents — it is the venue litigants choose. Spain concentrates patent disputes in a handful of specialised Commercial Courts (Juzgados de lo Mercantil), and only those in Barcelona, Madrid and Valencia are designated to hear them. Barcelona’s mercantile judges built their reputation over two decades, and counsel routinely file here for the technical depth of the bench and its willingness to grant fast, sometimes ex parte, preliminary injunctions. A patent assertion against a Catalan pharma, chemical or automotive company is filed at first instance before a Barcelona Commercial Court.

On appeal the case rises to Section 15 of the Provincial Court of Barcelona (Audiencia Provincial, Sección 15), the single most influential patent tribunal in Spain and the body whose case law seeded the specialised commercial-court system in the first place. A final cassation appeal lies to the Supreme Court (Tribunal Supremo) in Madrid. Because the same court weighs infringement and any validity defence together, the evidence that the accused product reads on the claim has to be litigation-ready from day one.

  • Barcelona Commercial Courts (Juzgados de lo Mercantil de Barcelona) — patent-designated first-instance forum, several sections handling patent and industrial-property actions
  • Provincial Court of Barcelona, Section 15 (Audiencia Provincial, Sección 15) — the specialised appellate bench whose precedent shapes Spanish patent law
  • Supreme Court (Tribunal Supremo) — the final cassation instance in Madrid
  • OEPM (Oficina Española de Patentes y Marcas) — the national office that grants and validates the patents being enforced

Spain outside the UPC: why national scope defines the analysis

The single fact that reshapes strategy in Barcelona is what does not apply. Spain is a founding member of the European Patent Convention, so European patents are granted, validated and enforced here — but Spain has not joined the Unified Patent Court and is not part of the Unitary Patent system. Spain declined to sign the UPC Agreement, so no unitary patent takes effect on Spanish soil, no UPC division sits in Spain, and the UPC’s central revocation and pan-European injunction simply cannot reach a Spanish right.

This is the exact opposite of Italy or Germany. A European patent reaches Barcelona only as a bundle of national Spanish rights validated before the OEPM, litigated in the Barcelona Commercial Courts under the 2015 Spanish Patent Act, which brought substantive examination into force in 2017. There is no unitary layer to opt into and no UPC route to defend against.

For an infringement analysis that matters enormously. A patentee running the same family across Europe cannot fold Spain into a UPC campaign, and an accused party cannot be hit with a unitary injunction that sweeps in Barcelona. The Spanish front is fought on its own national track, so the claim chart and evidence-of-use have to be built to Spanish procedural standards — for a Barcelona commercial-court complaint, for a preliminary injunction, and for diligencias de comprobación de hechos — never for a court with no power in Catalonia.

Barcelona’s industrial base: what the asserted patents claim

Barcelona’s litigation profile is written by the industries clustered around it. Catalonia hosts roughly half of Spain’s pharmaceutical output, and the sector’s champions are headquartered in and around the city — Grifols in plasma-derived biologics, Almirall in dermatology, and Esteve in specialty medicines — alongside a dense generics and CDMO base. Pharma is Spain’s most litigated patent field, and the asserted claims read on formulations, salts and polymorphs, second-medical-use indications, dosage regimens and manufacturing processes. Each one demands that infringement be proven against a specific marketed product or process, not asserted in the abstract.

Around the pharma core sits a heavy chemicals and materials base along the Llobregat and Tarragona corridors, generating process and composition patents where infringement often hides inside a manufacturing plant. The automotive complex adds a second stream: SEAT and the Volkswagen Group plant at Martorell, one of Europe’s largest car factories, sits at the centre of a Catalan supplier network whose patents cover powertrain, battery, safety and connected-vehicle systems.

A third and fast-growing stream flows from the 22@ innovation district in Poblenou, where food-tech, medtech and deep-tech start-ups file portfolios on connected devices, software-driven systems and novel food processes. Whether the technology is a polymorph, a chemical process, a driver-assistance module or a food-tech device, the commercial question is identical: does the accused product or process actually fall within the scope of the asserted claim? Answering it is exactly what an infringement analysis does.

Diligencias de comprobación de hechos: gathering the evidence

Spain gives a patentee a powerful tool to build the very evidence an infringement analysis needs. Under the 2015 Patent Act, a court may order diligencias de comprobación de hechos — fact-verification proceedings — that let a patentee inspect an alleged infringer’s premises, machinery, products and documents before suit is filed. They are granted only where infringement is presumable and cannot be verified any other way, and they exist precisely to avoid a long, costly trial when the infringing acts happen behind closed factory doors.

The mechanism carries a hard deadline that shapes the whole timetable. The certification of what the court found can be used only to bring the infringement action within 30 business days of delivery; miss that window and the measures lapse and the information cannot be used in any other proceeding. A Barcelona Commercial Court will also weigh confidentiality, so the inspection is framed to capture what proves the claim without exposing unrelated trade secrets.

Alongside fact-verification, Barcelona is known for granting preliminary injunctions, including ex parte where urgency is proven, and for the debate over how far validity can be examined at the interim stage. Both tools are only as strong as the claim mapping behind them: a judge asked to inspect a plant or freeze a launch needs a clear, element-by-element showing of why the accused product reads on the claim. That mapping is the deliverable, and it has to be ready before the diligencias are even requested.

How a patent infringement analysis Barcelona action turns on claim charts

Whether you are asserting a patent or defending against one, the case is won or lost on a single document: the claim chart that maps each element of the asserted claim onto the accused product or process. In a Barcelona commercial-court action the court expects that mapping to be concrete — tied to the marketed formulation, the plant process, the vehicle module or the device firmware — and supported by evidence-of-use that stands up to cross-examination and to any invalidity counterattack.

  • Element-by-element claim charts mapping every limitation of the asserted claim to the accused product or process
  • Evidence-of-use built from product teardowns, laboratory analysis, technical datasheets, regulatory dossiers and public technical literature
  • Doctrine-of-equivalents analysis where the accused product is not a literal match, argued to Spanish and EPC standards
  • Non-infringement and freedom-to-operate positions for an accused Catalan manufacturer, with claim construction pinned to the prosecution history
  • A package scoped to the forum — a Barcelona Commercial Court complaint, a preliminary-injunction application, or a request for diligencias de comprobación de hechos

The analysis cuts both ways. For a patentee it converts a suspicion into a pleadable infringement case and supports the urgency needed for interim relief. For an accused pharma, chemical or automotive company it builds the non-infringement read that keeps a product on the market and frames the validity defence that runs in the same action. Either way the decisive input is a rigorous, evidence-backed claim chart — not a conclusion asserted without proof.

How PerspireIP builds a Barcelona infringement-analysis file

Every engagement follows the same disciplined path. We construct the claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product or process. For pharma we work from formulations, polymorph data and regulatory dossiers; for chemicals from process and composition evidence; for automotive and food-tech from teardowns, firmware and technical datasheets — charting infringement literally and, where needed, under the doctrine of equivalents.

  • Claim construction and element-by-element charting to Spanish Patent Act and EPC standards
  • Evidence-of-use assembly — teardowns, lab analysis, datasheets, regulatory and public technical sources — dated and documented
  • Infringement and non-infringement positions built for either side of a Barcelona commercial-court dispute
  • Deliverables scoped to your forum: a first-instance complaint, a preliminary injunction, or the evidence base for diligencias de comprobación de hechos
  • Coordination with the national, non-UPC enforcement track and, where the family is European, with parallel proceedings abroad

We work alongside your Spanish and European counsel as a specialist analysis partner, deliver to Barcelona Commercial Court and OEPM deadlines, and keep every engagement confidential. Whether you are a Catalan pharma, chemical, automotive or food-tech company enforcing a patent, an accused party clearing a path to market, or litigation counsel preparing a complaint or a defence, we scale to fit — a single claim chart, a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis Barcelona project within one business day.

IP Landscape & Resources in Barcelona

Key intellectual-property authorities and venues relevant to Barcelona:

Request a Patent Infringement Analysis in Barcelona

Request a Patent Infringement Analysis in Barcelona

Get claim-chart mapping and evidence-of-use built for the Barcelona Commercial Courts — for a first-instance complaint, a preliminary injunction, or diligencias de comprobación de hechos, all on Spain’s national, non-UPC track. Send us the patent number and the accused product, and we will scope the work within one business day.

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions

Which court hears a patent infringement case in Barcelona?

The specialised Commercial Courts (Juzgados de lo Mercantil) of Barcelona hear patent infringement actions at first instance. Spain concentrates patent litigation in only Barcelona, Madrid and Valencia, and Barcelona is the venue counsel most often choose for the technical depth of its judges and its readiness to grant fast, sometimes ex parte, preliminary injunctions. Appeals go to Section 15 of the Provincial Court of Barcelona (Audiencia Provincial), the most influential patent bench in Spain, and a final cassation appeal lies to the Supreme Court in Madrid. Infringement and any validity defence are decided together in the same action.

Does the Unified Patent Court apply to a patent asserted in Barcelona?

No. Spain is a founding member of the European Patent Convention, but it did not join the Unified Patent Court and is not part of the Unitary Patent system. No unitary patent takes effect in Spain, there is no Spanish UPC division, and the UPC’s central revocation and pan-European injunction cannot reach a Spanish right. A European patent reaches Barcelona only as a national Spanish right validated before the OEPM and enforced in the Barcelona Commercial Courts under the 2015 Patent Act. This is the opposite of Italy or Germany, so a Spanish infringement analysis is built strictly for the national track and cannot be folded into a UPC campaign.

How can I gather evidence of infringement before suing in Barcelona?

Under the 2015 Spanish Patent Act you can ask a Barcelona Commercial Court for diligencias de comprobación de hechos — fact-verification proceedings that let you inspect the alleged infringer’s premises, machinery, products and documents. They are granted only where infringement is presumable and cannot be verified any other way, and the court frames them to protect unrelated trade secrets. The certification can be used only to file the infringement action within 30 business days of delivery, after which the measures lapse. Because the inspection has to target what proves the claim, an element-by-element claim chart should be ready before the diligencias are requested.

Why does a Barcelona infringement analysis need such detailed claim charts?

Because Barcelona’s patents come from pharma, chemicals, automotive and food-tech, and infringement in those fields turns on whether a specific formulation, plant process, vehicle module or device actually practises every element of the claim. A Barcelona Commercial Court expects a concrete, element-by-element mapping supported by evidence-of-use — teardowns, lab analysis, datasheets and regulatory data — that survives cross-examination and any invalidity counterattack. For a patentee the chart converts suspicion into a pleadable case and supports interim relief; for an accused Catalan company it builds the non-infringement read that keeps a product on the market. Either way, the claim chart is the document the case rests on.